Schedule 13D ownership disclosure

Shattuck Labs Inc

Common Stock, par value $0.0001 per share · CUSIP: 82024L103

Event date: 2025-08-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ORBIMED ADVISORS LLCReported CIK 0001055951

    Shares: 6,306,127.00 · Class: 9.99%

  • OrbiMed Capital GP IX LLCReported CIK 0001920574

    Shares: 5,255,106.00 · Class: 8.32%

  • OrbiMed Genesis GP LLCReported CIK 0001808744

    Shares: 1,051,021.00 · Class: 1.67%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-25-000841
Form type
SCHEDULE 13D
Filer
ORBIMED ADVISORS LLC
CIK
CIK 1055951
Filed
Sep 02, 2025
Reporting period
Aug 25, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub